The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α

碩士 === 高雄醫學大學 === 醫學遺傳學研究所 === 97 === Background and Purpose Dysregulation of the production of adipokines plays a pivotal role in the development of metabolic syndrome and cardiovascular comorbidity. Apelin , a newly identified adipokine, is novel up-regulated by insulin and obesity. The endogenous...

Full description

Bibliographic Details
Main Authors: Yi-Ning Li, 李依寧
Other Authors: Suh-Hang Hank Juo
Format: Others
Language:zh-TW
Published: 2009
Online Access:http://ndltd.ncl.edu.tw/handle/48318419732955662663
id ndltd-TW-097KMC05498004
record_format oai_dc
spelling ndltd-TW-097KMC054980042015-11-13T04:09:13Z http://ndltd.ncl.edu.tw/handle/48318419732955662663 The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α APLN基因多型性與代謝症候群之相關性以及TNF-α藥物治療下APLN的變化 Yi-Ning Li 李依寧 碩士 高雄醫學大學 醫學遺傳學研究所 97 Background and Purpose Dysregulation of the production of adipokines plays a pivotal role in the development of metabolic syndrome and cardiovascular comorbidity. Apelin , a newly identified adipokine, is novel up-regulated by insulin and obesity. The endogenous expression of Tumor necrosis factor-alpha (TNF-α) was reported a high correlation with apelin in adipocyte of human and rat. The purpose of present study is to investigate whether the polymorphisms at the gene encoding apelin confer risks for metabolic syndrome. The effect of TNF-α on expression of apelin will be also investigated. Methods The study subjects are volunteers who received health exam at the Kaohsiung Medical University Hospital. The diagnosis of metabolic syndrome is based on the modified version of National Cholesterol Education Program Adult Treatment Panel Ⅲ. We conducted a case-control association study using subjects with at least three of the five components of metabolic syndrome as cases and those with zero or one feature as controls. Four tagging SNPs at apelin gene were genotyped. We gathered clinical patients’ adipocyte primary cell culture. Isolated human adipose tissue-derived mesenchymal stem cells were induced to mature adipocyte then treated with TNF-α to measure apelin expression. Results A total of 498 cases and 1311 controls were included in the present study. Men were accounted for 51.4 % and the average age was 51.1 ?b 13.55 year-old. The four SNPs at the apelin gene were not statistically associated with metabolic syndrome. We further evaluated the apelin genetic effect on each of the five components of metabolic syndrome. SNP 3 appeared to be accounted for abdominal obesity (p = 0.023, adjusted age recessive model) and fasting glucose (p = 0.002, adjusted age dominant model). SNP 4 appeared to be accounted for abdominal obesity (p = 0.026, adjusted age dominant model). Apelin gene expression after 10 ng/ml TNF-α treated 1hour was significant different between sexual effect (p = 0.028). Conclusions The present study demonstrated that polymorphisms at the apelin gene may influence abdominal obesity and insulin resistance to the development of metabolic syndrome. Suh-Hang Hank Juo 卓夙航 2009 學位論文 ; thesis 79 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 高雄醫學大學 === 醫學遺傳學研究所 === 97 === Background and Purpose Dysregulation of the production of adipokines plays a pivotal role in the development of metabolic syndrome and cardiovascular comorbidity. Apelin , a newly identified adipokine, is novel up-regulated by insulin and obesity. The endogenous expression of Tumor necrosis factor-alpha (TNF-α) was reported a high correlation with apelin in adipocyte of human and rat. The purpose of present study is to investigate whether the polymorphisms at the gene encoding apelin confer risks for metabolic syndrome. The effect of TNF-α on expression of apelin will be also investigated. Methods The study subjects are volunteers who received health exam at the Kaohsiung Medical University Hospital. The diagnosis of metabolic syndrome is based on the modified version of National Cholesterol Education Program Adult Treatment Panel Ⅲ. We conducted a case-control association study using subjects with at least three of the five components of metabolic syndrome as cases and those with zero or one feature as controls. Four tagging SNPs at apelin gene were genotyped. We gathered clinical patients’ adipocyte primary cell culture. Isolated human adipose tissue-derived mesenchymal stem cells were induced to mature adipocyte then treated with TNF-α to measure apelin expression. Results A total of 498 cases and 1311 controls were included in the present study. Men were accounted for 51.4 % and the average age was 51.1 ?b 13.55 year-old. The four SNPs at the apelin gene were not statistically associated with metabolic syndrome. We further evaluated the apelin genetic effect on each of the five components of metabolic syndrome. SNP 3 appeared to be accounted for abdominal obesity (p = 0.023, adjusted age recessive model) and fasting glucose (p = 0.002, adjusted age dominant model). SNP 4 appeared to be accounted for abdominal obesity (p = 0.026, adjusted age dominant model). Apelin gene expression after 10 ng/ml TNF-α treated 1hour was significant different between sexual effect (p = 0.028). Conclusions The present study demonstrated that polymorphisms at the apelin gene may influence abdominal obesity and insulin resistance to the development of metabolic syndrome.
author2 Suh-Hang Hank Juo
author_facet Suh-Hang Hank Juo
Yi-Ning Li
李依寧
author Yi-Ning Li
李依寧
spellingShingle Yi-Ning Li
李依寧
The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
author_sort Yi-Ning Li
title The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
title_short The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
title_full The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
title_fullStr The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
title_full_unstemmed The association of APLN polymorphisms with metabolic syndrome and the change of APLN gene expression treated with TNF-α
title_sort association of apln polymorphisms with metabolic syndrome and the change of apln gene expression treated with tnf-α
publishDate 2009
url http://ndltd.ncl.edu.tw/handle/48318419732955662663
work_keys_str_mv AT yiningli theassociationofaplnpolymorphismswithmetabolicsyndromeandthechangeofaplngeneexpressiontreatedwithtnfa
AT lǐyīníng theassociationofaplnpolymorphismswithmetabolicsyndromeandthechangeofaplngeneexpressiontreatedwithtnfa
AT yiningli aplnjīyīnduōxíngxìngyǔdàixièzhènghòuqúnzhīxiāngguānxìngyǐjítnfayàowùzhìliáoxiàaplndebiànhuà
AT lǐyīníng aplnjīyīnduōxíngxìngyǔdàixièzhènghòuqúnzhīxiāngguānxìngyǐjítnfayàowùzhìliáoxiàaplndebiànhuà
AT yiningli associationofaplnpolymorphismswithmetabolicsyndromeandthechangeofaplngeneexpressiontreatedwithtnfa
AT lǐyīníng associationofaplnpolymorphismswithmetabolicsyndromeandthechangeofaplngeneexpressiontreatedwithtnfa
_version_ 1718129163652562944